Protocol biopsies in the management of renal allograft recipients

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 6, 2000, Pages 615-619

  Rush, David ^a,b   Nickerson, Peter ^a   Jeffery, John ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MOLECULAR BIOLOGY; NEPHRITIS; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RENOGRAPHY; REVIEW; STANDARDIZATION;

BIOPSY; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MOLECULAR BIOLOGY; POSTOPERATIVE PERIOD; SAFETY;

EID: 0033709695     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200011000-00005     Document Type: Review

References (31)

1. Time dependency of factors affecting renal allograft survival
2. The Banff 97 working classification of renal allograft pathology
3. Living donor kidney transplants: A biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years
4. Outcome of kidney transplantation from high-risk donors is determined by both structure and function
5. Biopsy of marginal donor kidneys: Correlation of histologic findings with graft dysfunction
6. Histopathological findings in renal allografts at time of transplantation and correlation with onset of graft function
7. Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function
8. Predictors of renal transplant histology at three months
9. Cadaver versus living donor kidneys: Impact of donor factors on antigen induction before transplantation
10. Routine early biopsy of allografts with delayed function: Correlation of histology and graft outcome
11. Weekly protocol renal transplant biopsies allow detection of sub-clinical acute rejection episodes in patients with delayed graft function
12. Beneficial effects of treatment of early subclinical rejection: A randomized study
13. Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: A pilot study
14. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients
15. Quantification of fibrosis and correlation with immunoactivation markers on protocol kidney allograft biopsies
16. Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: Does dyssynchronous rejection really exist?
17. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: An interim report
18. Subclinical acute rejection: Is it a cause of chronic rejection in renal transplantation?
19. Predicting rejection: Is early diagnosis achievable and important?
20. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages
21. Histological outcome of acute cellular rejection in kidney transplantation after treatment with methylprednisolone
22. Correlation of histology to clinical rejection reversal: A thymoglobulin multicenter trial report
23. Computerized histomorphometric assessment of protocol renal biopsy specimens for surrogate markers of chronic rejection
24. Protocol biopsy prediction of long term renal allograft survival: Using computerized image analysis of sirius red staining
25. Protocol core biopsy (CADI): A surrogate marker for chronic rejection. Mycophenolate Mofetil ICM 1866 and IICR 023 Study Groups
26. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy
27. Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function
28. Immune-activation gene expression in clinically stable renal allograft biopsies: Molecular evidence for subclinical rejection
29. Intragraft expression of transforming growth factor beta1 gene in isolated glomeruli from human renal transplants
30. Comparison of the expression of fibrosis associated genes in glomeruli after renal transplantation between conventional cadaveric and non-heart-beating donors
31. Subclinical rejection - A potential surrogate marker for chronic rejection - May be diagnosed by protocol biopsy of urine spectroscopy